Oral E. coli Vaccine Promising

Article

The August 2000 issue of the journal Infection and Immunity published findings that seem promising for an experimental oral vaccine against pathogenic Escherichia coli. Currently being tested on Israeli military volunteers, the vaccine appears to be safe and to stimulate an appropriate immune response. The study was conducted by researchers from the Israeli Defense Force; Tel Aviv University; Technion-Israel Institute of Technology; University of Negrev; Hebrew University and Hassadah Medical School, Jerusalem; the Walter Reed Army Institute of Research, Washington, DC; and the University of Goteborg, Sweden. For more information visit www.asm.usa.org.

Recent Videos
Anthony Bondon CRCST, CHL, BSM, AAS, SME, LSSYB
Deannard Esnard, CRCST, CIS, CER, CHL, CFER, CQUIA
Kevin Bush, Jr, DHSc, EdD, MSHA, MA, MS, FACHE
Vatsala Rangachar Srinivasa, MPH
Sarah Vinson, MBA, CRCST
Kevin Anderson, MBA, BS, CRCST, Senior Manager, Commercial Education Services, Heatlthmark, a Getinge Company
Damien Berg, BA, BS, CRCST, AAMIF, is the vice president of strategic initiatives for the HSPA.
Annet Adegboyega, DNP, MSN, BSN, RN, CNOR; Mihyun "Rose" Jang, MSN, MPH, BSN, RN, CNOR; and Renilda Tijones, MSN, BSN, RN, CNOR.
Roundtable of Vet IPs (Adobe Stock)
APIC 2025 President Carol McLay, DrPH, MPH, RN, CIC FAPIC   (Image credit: APIC)
Related Content